Zobrazeno 1 - 10
of 27
pro vyhledávání: '"G. Chenuc"'
Autor:
C. Esnault, V. Barbet, T. Filleron, G. Chenuc, M. Pérol, D. Debieuvre, N. Girard, X. Quantin, K. Thokagevistk, G. Simon, L. Baschet
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 70:S266-S267
Autor:
M. Pérol, X. Quantin, H. Lena, T. Filleron, C. Chouaid, C. Audigier Valette, C. Kaderbhai, G. Chenuc, M. Santorelli, L. Bensimon, T. Burke, G. Simon, A.L. Martin, D. Debieuvre, R. Gervais, R. Schott, M. Carton, L. Bosquet, N. Girard
Publikováno v:
Revue des Maladies Respiratoires Actualités. 14:205-206
Autor:
M. Pérol, T. Filleron, X. Quantin, C. Chouaid, C. Audigier-Valette, H. Lena, C. Kaderbhai, G. Chenuc, M. Santorelli, L. Bensimon, T. Burke, L. Bosquet, E. Nguyen, G. Simon
Publikováno v:
Revue des Maladies Respiratoires Actualités. 14:205
Autor:
G. Chenuc, Laurence Bozec, Jessy Delaye, Esma Saada, Sophie Piperno-Neumann, Florence Duffaud, I.L. Ray-Coquard, N. Isambert, Emmanuelle Bompas, Didier Cupissol, Christine Chevreau, J.-C. Eymard, C. Guillemet, Jacques-Olivier Bay, Maria Rios, Nicolas Penel, Antoine Italiano, François Bertucci, Corinne Delcambre, Patricia Pautier
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2020, 125, pp.31-37. ⟨10.1016/j.ejca.2019.10.028⟩
European Journal of Cancer, Elsevier, 2020, 125, pp.31-37. ⟨10.1016/j.ejca.2019.10.028⟩
Background Options in second-line therapy after doxorubicin-based chemotherapy for metastatic/advanced leiomyosarcoma include gemcitabine (G), trabectedin and pazopanib (P) monotherapy. Currently, no combination therapy is better than monotherapy. LM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0107c14f51538cc391d83fa56795ad4
https://hal.archives-ouvertes.fr/hal-02429038
https://hal.archives-ouvertes.fr/hal-02429038
Autor:
Maurice Pérol, G. Chenuc, Nicolas Girard, C. Courtinard, Gaëtane Simon, Thomas Burke, Thomas Filleron, A-L. Martin, Didier Debieuvre, Xavier Quantin, L. Bensimon, Radj Gervais, Christos Chouaid, Matthieu Carton, Roland Schott, C. Audigier Valette, M. Santorelli, Coureche Kaderbhai, Hervé Lena
Publikováno v:
Journal of Thoracic Oncology. 16:S758
Autor:
Alexia Savignoni, G. Chenuc, D. Pérol, C. Courtinard, Raphaël Porcher, M. Robain, Suzette Delaloge, M. Ezzalfani
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 66:S141-S142
Introduction In 2014, the RD IV should not be correlated to the output (OS) and affect the OS only indirectly through its effect on the treatment. We used “Activity level of FCCC”, which represents the number of cases in the whole database per co
Autor:
A. Gonçalves, Bernard Asselain, Laurence Vanlemmens, G. Chenuc, T. Guesmia, Veronique Lorgis, Marc Debled, Thomas Bachelot, M. Robain, M.-A. Mouret-Reynier, D. Perol, Etienne Brain, Suzette Delaloge, L. Uwer, M. Campone, Florence Dalenc, C. Cailliot, P. Kerbrat, Véronique Diéras, Thierry Petit, Corinne Veyret, Christelle Jouannaud, William Jacot, J-M Ferrero, C. Courtinard, Christine Levy
Publikováno v:
Annals of Oncology
Annals of Oncology, 2016, 27 (9), pp.1725-1732. ⟨10.1093/annonc/mdw260⟩
Annals of Oncology, Oxford University Press (OUP), 2016, 27 (9), pp.1725-1732. ⟨10.1093/annonc/mdw260⟩
Annals of Oncology, Elsevier, 2016, 27 (9), pp.1725-1732. ⟨10.1093/annonc/mdw260⟩
Annals of Oncology, 2016, 27 (9), pp.1725-1732. ⟨10.1093/annonc/mdw260⟩
Annals of Oncology, Oxford University Press (OUP), 2016, 27 (9), pp.1725-1732. ⟨10.1093/annonc/mdw260⟩
Annals of Oncology, Elsevier, 2016, 27 (9), pp.1725-1732. ⟨10.1093/annonc/mdw260⟩
Background Bevacizumab combined with paclitaxel as first-line chemotherapy for patients with HER2-negative metastatic breast cancer (MBC) has led to mixed results in randomized trials, with an improvement in progression-free survival (PFS) but no sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0bcaa6933153d824716b0b2e51ee0a6
https://hal.science/hal-02262350
https://hal.science/hal-02262350
Autor:
Emmanuelle Bompas, Antoine Italiano, François Bertucci, Maria Rios, C. Delcambre, J-O. Bay, Didier Cupissol, I.L. Ray-Coquard, Antoine Thyss, Patricia Pautier, N. Isambert, J. Delaye, G. Chenuc, Christine Chevreau, L. Bozec Le Moal, J.-C. Eymard, C. Guillemet, Florence Duffaud, Sophie Piperno-Neumann, Nicolas Penel
Publikováno v:
Annals of Oncology. 28:v646
Publikováno v:
Value in Health. 16(7)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.